CIP2A is an oncogenic cellular inhibitor of PP2A, and overexpression of CIP2A inhibits PP2A, thereby causing various kinase-driven signaling activations, which promote tumor growth and aggressiveness [22,23,24]. This evidence concerns the gene PTPA and neoplasm.